Who
Yaron Naos
Sr. VP & COO
Company insider
Files Form 4 as: Sr. VP & COO, Protalix BioTherapeutics, Inc. (DE).
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Sep 2018
- Last trade
- 3 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Sep 2026filed 4 Sep 2026 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —112,000 at $0.00 | filing |
| 3 Sep 2026filed 4 Sep 2026 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —56,000 at $0.00 | filing |
| 3 Sep 2026filed 4 Sep 2026 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —112,000 at $0.00 | filing |
| 3 Sep 2026filed 4 Sep 2026 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —56,000 at $0.00 | filing |
| 3 Sep 2025filed 4 Sep 2025 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 3 Sep 2025filed 4 Sep 2025 | PLX Protalix BioTherapeutics, Inc. (DE)Biotechnology | SEC FORM 4 Code A | —25,000 | filing |
| 23 Sep 2024filed 24 Sep 2024 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 15 Aug 2023filed 17 Aug 2023 | PLX Protalix BioTherapeutics, Inc. (DE)Biotechnology | SEC FORM 4 Code A | —187,344 | filing |
| 7 Sep 2022filed 9 Sep 2022 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —340,000 at $0.00 | filing |
| 11 Aug 2020filed 13 Aug 2020 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —122,656 at $0.00 | filing |
| 13 Sep 2018filed 14 Sep 2018 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.